50561
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 50561, covering 2025-09-18 to 2025-09-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease [Phase 2]